Submitted by Anonymous (not verified) on 5 December 2024 - 12:45
Human medicines European public assessment report (EPAR): Supemtek, Quadrivalent influenza vaccine (recombinant, prepared in cell culture), Date of authorisation: 16/11/2020, Revision: 6, Status: Authorised
Source: